Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Do Cao

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Presse Medicale (Paris, France : 1983)|January 17, 2009
[Current management of thyroid malignancies]Christine Do Cao, Jean-Louis Wémeau
Presse Medicale (Paris, France : 1983)|July 9, 2017
[Oral and dental expression of thyroid diseases]Jean-Louis Wémeau, Christine Do Cao, Miriam Ladsous
Bulletin Du Cancer|November 6, 2024
Christine Do Cao, Antoine Danais, Paul Schwartz, et al.
Annales D'Endocrinologie|January 16, 2025
Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumorChristine Do Cao, Niki Christou, Julien Hadoux, et al.
Annales D'Endocrinologie|August 22, 2018
Expert opinion on thyroid complications of new anti-cancer therapies: Tyrosine kinase inhibitorsDelphine Drui, Frédéric Illouz, Christine Do Cao, et al.
Annales D'Endocrinologie|August 22, 2018
Expert opinion on thyroid complications in immunotherapyFrederic Illouz, Delphine Drui, Philippe Caron, et al.
Bulletin Du Cancer|February 25, 2018
[Autoimmune hypophysitis associated with new anti-cancer immunotherapies]Arnaud Jannin, Emilie Merlen, Christine Do Cao, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN TUTHYREF network consensus recommendations for refractory thyroid cancer managementLivia Lamartina, Julien Hadoux, Françoise Borson-Chazot, et al.
La Revue Du Praticien|June 8, 2023
[Exploration and management of thyroid nodules]Hamza Benderradji, Christine Do Cao, Miriam Ladsous, et al.
Journal of Nephrology|July 7, 2023
Proteinuria reduction with SGLT2 inhibitors in a patient treated with tyrosine kinase inhibitor lenvatinibVictor Fages, Arnaud Jannin, Mehdi Maanaoui, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Presse Medicale (Paris, France : 1983)|January 17, 2009
[Current management of thyroid malignancies]Christine Do Cao, Jean-Louis Wémeau
Presse Medicale (Paris, France : 1983)|July 9, 2017
[Oral and dental expression of thyroid diseases]Jean-Louis Wémeau, Christine Do Cao, Miriam Ladsous
Bulletin Du Cancer|November 6, 2024
Christine Do Cao, Antoine Danais, Paul Schwartz, et al.
Annales D'Endocrinologie|January 16, 2025
Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumorChristine Do Cao, Niki Christou, Julien Hadoux, et al.
Annales D'Endocrinologie|August 22, 2018
Expert opinion on thyroid complications of new anti-cancer therapies: Tyrosine kinase inhibitorsDelphine Drui, Frédéric Illouz, Christine Do Cao, et al.
Annales D'Endocrinologie|August 22, 2018
Expert opinion on thyroid complications in immunotherapyFrederic Illouz, Delphine Drui, Philippe Caron, et al.
Bulletin Du Cancer|February 25, 2018
[Autoimmune hypophysitis associated with new anti-cancer immunotherapies]Arnaud Jannin, Emilie Merlen, Christine Do Cao, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN TUTHYREF network consensus recommendations for refractory thyroid cancer managementLivia Lamartina, Julien Hadoux, Françoise Borson-Chazot, et al.
La Revue Du Praticien|June 8, 2023
[Exploration and management of thyroid nodules]Hamza Benderradji, Christine Do Cao, Miriam Ladsous, et al.
Journal of Nephrology|July 7, 2023
Proteinuria reduction with SGLT2 inhibitors in a patient treated with tyrosine kinase inhibitor lenvatinibVictor Fages, Arnaud Jannin, Mehdi Maanaoui, et al.
Pageof 12